Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
CAS Number: N/A
Product Code: REF-QT03918
Molecular formula: N/A
Molecular weight: N/A
Purity: 91.46%
Product nature: Separation and purification
Appearance: Solid
Storage conditions: -20 ℃
Hot Tags:Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification), China, suppliers, manufacturers, factory, customized, price, pricelist, in stock。
Synthesis of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification) Reference Standards,
Complex Impurity Of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Chemical Standards of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Characterization Of Unknown Impurities of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Structure Profiling of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Identification of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Isolation & Purification of Impurity of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Difficult of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Instability of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Low-assay of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
Complex Impurity Of Chemical Standards of Unknown Impurity 1 of Fluoxef Sodium for Injection (Separation and Purification)
TOSUN PHARM was established in 1999. In China, it is a collection of drugs, APIs, reference listed drugs, impurities, excipients, intermediates import and export, import registration services, generic drug research and development services, innovative drugs and high-end FDF technology transfer, A group company integrating marketing, academic promotion and cooperative production. With a global procurement, R&D and marketing network, it can quickly meet the needs of product R&D, production and market sales of Chinese and global pharmaceutical companies.
China
